cyanogenic glycosides in plant foodsetheses.whiterose.ac.uk/5002/1/islamiyat bolarinwa thesis...
TRANSCRIPT
Cyanogenic Glycosides in Plant Foods
Islamiyat Folashade Bolarinwa
Submitted in accordance with the requirements for the degree of
Doctor of Philosophy
to
The University of Leeds
School of Food Science and Nutrition
May 2013
2
The candidate confirms that the work submitted is her own and that appropriate
credit has been given where reference has been made to the work of others.
This copy has been supplied on the understanding that it is copyright material and
that no quotation from the thesis may be published without proper
acknowledgement.
The right of Islamiyat Folashade Bolarinwa to be identified as author of this work
has been asserted by her in accordance with the copyright, Designs and Patents Act
1988.
©2013
The University of Leeds
Islamiyat Folashade Bolarinwa
i
ACKNOWLEDGEMENTS
I would like to express my sincere gratitude to my supervisors
Professor Mike Morgan and Dr Caroline Orfila for their guidance,
constructive comment, patience and support during the course of this
project.
I would like to thank Dr Lisa Marshall for allowing me to use the hplc
in her laboratory.
I am very grateful to Education Trust Fund (ETF) of Nigeria and to
Ladoke Akintola University of Technology (LAUTECH) for funding this
research.
I would like to thank my colleagues, Nasser Al-Shabib, Swen Langer,
Merfat Al-Maghrabi, Heba Sindi, Hanis Yahyah, Ebun Oladele, Wessal
Almabruk, Sarah Hamli, Maha Thaiban, Abdul-rahman Sweiden and Nicola
Kraut for their friendship, good humour and helpful nature that help to create
an excellent working environment.
I am grateful to all members of staff of the School of Food Science
and Nutrition. Especially Dr Mahmood Akhtar, Dr Melvin Holmes, Dr Tristan
Dew, Mr Ian Hardy, Mr Mattew Taylor, Mr Paul Kajda and Mr Miles Ratcliffe
for their help and assistance.
Special thanks to my sister, Dr S.T.Taiwo for her spiritual and
financial support, and to Dr A. Salaudeen and family for their precious help
and support.
Many thanks to my lovely kids, Abeedah, Abubakr and Aisha and my
husband, Mr A. Bolarinwa for their endurance, patience, support and love
during the course of this project.
ii
ABSTRACT
Consumption of cyanogenic plants can cause serious health problems for
humans. The ability to detect and quantify cyanogenic glycosides, capable of
generating cyanide, could contribute to prevention of cyanide poisoning from
the consumption of improperly processed cyanogenic plants. In the first part
of the present study, an efficient extraction method for amygdalin from foods
was developed by comparing the extraction efficiency of water and ethanol
at room and boiling temperature for various extraction times. Efficiencies of
the extraction methods were evaluated by using a modified HPLC method.
In general, boiling ethanol was more efficient for amygdalin extraction from
foods. Amygdalin contents of a wide range of commercially-available food
products were determined for the first time. In the second part, the effect of
processing on amygdalin levels in apple juice was investigated. Apple juices
produced from different apple varieties were subjected to various processing
conditions such as freezing, pasteurization and holding for various times.
The results obtained showed that processing can result in reduction of
amygdalin level in apple juice and that the reduction of amygdalin by
enzymatic degradation probably depends on the level of the enzyme in the
processed foods and the utilisation of optimum conditions for the enzyme
activities. High-temperature treated commercially-available apple juice had
lower amygdalin levels compared to low-temperature treated juices,
indicating the degradation of amygdalin at high processing temperatures. In
the last part, the development of a sensitive ELISA method for amygdalin
was investigated. Antibody produced by using an immunogen that was
synthesized using the cyanuric chloride method for coupling of hapten to
carrier protein was highly immunoreactive and very specific for amygdalin.
The ELISA developed using this antibody was very sensitive (LOD =
0.2ng/ml). The results obtained from the determination of amygdalin in foods
using the ELISA method showed excellent correlation with those obtained
from HPLC method.
The work described is the first comprehensive study on detection of a
particular cyanogenic glycoside and use of an antibody-based method for
determination of amygdalin in processed foods. The results obtained
suggested that while the consumption of products available in the UK with
the potential for containing amygdalin are unlikely to present a health risk to
consumers, monitoring of new processing protocols would be wise.
iii
Publications Arising From Research in the Thesis
Islamiyat F. Bolarinwa, Caroline Orfila, Michael R.A. Morgan (2013)
Amygdalin Content of Seeds, Kernels and Food Products Commercially-
available in the UK. Submitted manuscript.
Conference presentations
Islamiyat F. Bolarinwa, Caroline Orfila, Michael R.A. Morgan. Poster
presentation: Improving Detection Methods for Cyanogenic Glycosides in
Foods. First Africa College International Conference on Food security,
Health and Impact Knowledge Brokering, Leeds, England, UK, June, 2011.
Islamiyat F. Bolarinwa, Caroline Orfila, Michael R.A. Morgan. Poster
presentation: An Enzyme-linked Immunosorbent Assay (ELISA) for the
Determination of Amygdalin, a Cyanogenic Glycoside, in Foods. 245th
American Chemical Society National Meeting and Exposition on Chemistry
of Energy and Food, New Orleans, Louisiana, USA, April, 2013.
iv
CONTENTS
Page
List of figures xiii
List of tables xviii
Abbreviations xx
Chapter 1: Introduction 1
1.1 Plant toxins 1
1.1.1 Cyanogenic glycosides 7
1.1.1.1 Biosynthesis of cyanogenic glycosides 11
1.1.1.2 Cyanogenesis 13
1.1.1.3 Enzymatic hydrolysis of cyanogenic glycosides
in food plants
14
1.1.1.4 Mechanism of cyanide poisoning 18
1.1.1.5 Clinical manifestation of cyanide poisoning 20
1.1.1.6 Treatment of cyanide poisoning 20
1.1.1.7 Human health effect of cyanogenic
Glycosides
22
1.1.1.8 Mechanism of cyanide detoxication in
Human
24
1.1.1.9 Toxicity of cyanogenic glycosides 26
1.1.1.10 Prevention of cyanide-induced disease 28
1.1.1.11 Analysis of cyanogenic glycosides 29
1.2 Immunoassay 32
1.2.1 Definition 33
1.2.2 Enzyme-linked immunosorbent assay 33
v
1.2.3 Advantages of enzyme-immunoassay methods 38
1.2.4 Immunoassay applied to food 39
1.2.4.1 Determination of pesticide residue 41
1.3 Antibodies 42
1.3.1 Antigen-antibody reaction 44
1.3.2 Antibody production 47
1.3.2.1 Polyclonal antibodies 47
1.3.2.2 Monoclonal antibodies 48
1.3.2.3 Recombinant antibodies 50
1.3.2.4 Antibody production against haptens 51
1.3.2.5 Secondary antibody 55
1.3.2.6 Antibody titre 55
1.3.2.7 Antibody specificity 55
1.4 Aims of the project 57
Chapter 2: Materials and Methods 58
2.1 Chemicals, disposable items and solvents 58
2.2 Equipment 60
2.3 Food samples 62
2.4 High performance liquid chromatography (HPLC) 63
2.4.1 HPLC consumables 64
2.4.2 HPLC equipment 64
2.4.2.1 Autosampler 65
2.4.2.2 Detector 66
2.4.3 HPLC method 68
2.4.4 Identification and quantification of amygdalin by
HPLC
68
2.4.5 Optimisation of amygdalin extraction from almond
Kernels
69
2.4.5.1 Water extraction at 37oC 69
vi
2.4.5.2 Water extraction at 100oC 70
2.4.5.3 Ethanol extraction at 37oC 70
2.4.5.4 Ethanol extraction at 78.5oC 70
2.4.5.5 Extraction efficiency 71
2.4.6 Extraction of amygdalin from foods 71
2.4.7 Preparation of extracts for HPLC analysis 72
2.5 Apple juice 74
2.5.1 Apple juice extraction 74
2.5.1.1 Apple juice from whole apple 74
2.5.1.2 Processing of apple juice and determination
of amygdalin content
74
2.5.2 Commercially-available apple juice 75
2.6 ELISA experiments 76
2.6.1 Preparation of buffers and solutions 76
2.6.2 Hapten-protein conjugates 78
2.6.3 Synthesis of hapten-protein conjugates 79
2.6.3.1 Periodate cleavage conjugation method 79
2.6.3.1.1 Amygdalin-BSA conjugates 79
2.6.3.1.2 Amygdalin-KLH conjugates 79
2.6.3.2 Chemical optimisation of cyanuric chloride
conjugation procedure
80
2.6.3.2.1 Spectrophotometric studies 81
2.6.3.2.2 Determination of optimum molar ratio of
naringin and BSA for naringin-BSA conjugate
production
81
2.6.3.3 Cyanuric chloride conjugation method 82
2.6.3.3.1 Amygdalin-BSA conjugates 82
2.6.3.3.2 Amygdalin-KLH conjugates 82
2.6.4 Assessment of hapten-protein conjugates 86
2.6.4.1 UV-spectrophotometric method 86
vii
2.6.4.2 Chemical method 86
2.6.5 Polyclonal antibody production 88
2.6.6 Determination of antibody titre curves 88
2.6.7 Standard curve for indirect competitive ELISA 90
2.6.8 Optimisation of indirect competitive ELISA (icELISA) 91
2.6.9 Cross-reaction determinations 91
2.6.10 Determination of matrix effect 92
2.7 Statistical analysis 94
Chapter 3: Optimisation of Extraction and Quantification of Amygdalin
by HPLC; in Seeds, Kernels and Food Products Available in the UK 95
3.1 Introduction 96
3.1.1 Aim of the chapter 99
3.2 Methods 100
3.2.1 HPLC method 100
3.2.2 Determination of amygdalin calibration curves 100
3.2.3 Optimisation of amygdalin extraction from almond
Kernels
100
3.2.4 Extraction efficiency 100
3.2.5 Extraction of amygdalin from fruit kernels and
food products
100
3.3 Results 101
3.3.1 Separation of amygdalin by reversed–phase
HPLC-UV
101
3.3.2 Optimisation of amygdalin extraction from
Almonds
102
3.3.2.1 Water extraction at 37oC 106
3.3.2.2 Water extraction at 100oC 107
viii
3.3.2.3 Ethanol extraction at 37oC 108
3.3.2.4 Ethanol extraction at 78.5oC 109
3.3.3 Extraction efficiency 111
3.3.4 Amygdalin contents of kernels, seeds and
processed products
113
3.3.4.1 Amygdalin contents of kernels 113
3.3.4.2 Amygdalin contents of seeds 116
3.3.4.3 Amygdalin contents of processed
Products
118
3.3.5 Discussion 120
3.4 Conclusions 125
Chapter 4: Effects of Processing on Amygdalin Levels in
Apple Juice 126
4.1 Introduction 127
4.1.1 Aim of the chapter 129
4.2 Methods 130
4.2.1 Apple juice extraction 130
4.2.1.1 Apple juice from whole apple 130
4.2.1.2 Processing of apple juice and determination
of amygdalin content
130
4.2.2 Commercially-available apple juice 130
4.2.3 Extraction of amygdalin from apple juice 130
4.2.4 Extraction of amygdalin from apple seeds 130
4.2.5 Extraction efficiency 131
4.3 Results 132
ix
4.3.1 HPLC analysis of amygdalin 132
4.3.2 Amygdalin content of apple seeds 133
4.3.3 Amygdalin contents of apple juices made from
apple flesh without core, apple flesh with core
and whole apple136
4.3.4 Effect of processing on the amygdalin content of
apple juice made from whole apple139
4.3.5 Commercially-available apple juice 145
4.3.5.1 Apple juice from pressed/squeezed fruit 145
4.3.5.2 Long-life apple juice 145
4.3.6 Discussion 148
4.4 Conclusions 154
Chapter 5: Production of Antibody against Amygdalin 155
5.1 Introduction 156
5.1.1 Aim of the chapter 160
5.2 Methods 161
5.2.1 Synthesis of hapten-protein conjugates 161
5.2.2 Assessment of hapten-protein conjugates 161
5.2.3 Polyclonal antibody production 161
5.2.4 Determination of anti-amygdalin titre curve 161
5.2.5 Development of an ELISA standard curve for
amygdalin
162
5.3 Results 162
5.3.1 Chemistry of the immunogens 162
x
5.3.1.1 Periodate cleavage conjugation method 162
5.3.1.2 Chemical optimisation of cyanuric chloride
conjugation procedure
163
5.3.1.2.1 Spectrophotometric studies 163
5.3.1.2.2 Determination of optimum molar ratio
of naringin in naringin-BSA conjugate
165
5.3.1.3 Cyanuric chloride conjugation method 168
5.3.2 Verification of hapten-protein conjugates 169
5.3.2.1 Spectrophotometric studies 169
5.3.2.2 Chemical method 172
5.3.3 Anti-amygdalin antibody titre 176
5.3.3.1 Antibody titre from periodate cleavage
Immunogen
176
5.3.3.2 Antibody titre from cyanuric chloride
Immunogen
180
5.3.4 Competitive ELISA 183
5.3.4.1 Standard curve obtained by using antibody
from the periodate cleavage method
183
5.3.4.2 Amygdalin standard curve obtained by using
antibody from the cyanuric chloride
conjugation method
188
5.3.4.3 Characterisation of competitive ELISA
standard curve of amygdalin
189
5.3.5 Discussion 191
5.4 Conclusion 198
xi
Chapter 6: Characterisation of an ELISA for Determination of
amygdalin in Food Products 200
6.1 Introduction 201
6.1.1 Aim of the chapter 203
6.2 Methods 204
6.2.1 Optimisation of the indirect competitive ELISA
(icELISA) method
204
6.2.2 Cross-reaction determination 204
6.2.3 Determination of matrix effect 204
6.2.4 Determination of amygdalin in food products 204
6.3 Results 205
6.3.1 Optimisation of the indirect competitive ELISA
(icELISA) method
205
6.3.2 Cross-reaction of the polyclonal anti-amygdalin
Antibody
210
6.3.3 Matrix effect 213
6.3.4 Determination of amygdalin in food products 215
6.3.5 Discussion 218
6.4 Conclusion 223
Chapter 7: General Discussion, Suggestions for Future Work and
Conclusion 224
7.1 General discussion 224
7.1.1 Extraction of amygdalin from foods 227
7.1.2 Effect of processing on amygdalin 228
7.1.3 Development of an ELISA method for amygdalin 229
xii
7.2 Suggestions for future work 231
7.3 Conclusion 232
Chapter 8: References 233
Appendices 254
xiii
List of figures
Figure 1-1 Structures of example of plant toxins 3
Figure 1-2 The biosynthetic pathway for cyanogenic glycosides
from its precursor amino acid
12
Figure 1-3 The structures and hydrolytic products of linamarin and
dhurrin
17
Figure 1-4 Enzymatic hydrolysis of amygdalin and prunasin to form
hydrogen cyanide
18
Figure 1-5 The reaction of cyanide with 3-mercaptopyruvate to form
sulfur and thiosulfate
26
Figure 1-6 Non-competitive ELISA assay showing the capture
antibodies and the detector antibodies
35
Figure 1-7 The general structure of antibody (IgG molecule)
showing the heavy and the light chains and the antibody
binding site
43
Figure 1-8 Schematic representation of antigen-antibody linkage
showing the intermolecular forces involved in antibody-
antigen reactions
46
Figure 1-9 A schematic representation of hapten on a carrier
molecule
53
Figure 1-10 Procedure for antibody production against hapten 54
Figure 2-1 Image of the Shimadzu HPLC used in this study 67
Figure 2-2 A schematic representation of the extraction of
amygdalin from food
73
Figure 2-3 A scheme showing the route for amygdalin-BSA
conjugate synthesis using the periodate cleavage
method
83
xiv
Figure 2-4 A scheme showing the route for amygdalin-CC (hapten)
synthesis
84
Figure 2-5 A scheme showing the route for amygdalin-BSA
conjugate synthesis using cyanuric chloride conjugation
method
85
Figure 2-6 Images showing colour development in competitive
ELISA
93
Figure 3-1 Spectra of amygdalin standard in water at different
wavelengths
103
Figure 3-2 Chromatograms of amygdalin standard showing
detection sensitivity of amygdalin at different
wavelengths
104
Figure 3-3 Reversed-phase HPLC of amygdalin 105
Figure 3-4 The amygdalin calibration curve for peak area against
concentration of amygdalin 106
Figure 3-5 Extraction yield (mg/100g) of amygdalin from almonds
using water at (37oC and 100oC) and ethanol at (37oC
and 78.5oC)
110
Figure 3-6 Water and ethanol extracts of amygdalin from almond
kernels
111
Figure 3-7 Stability of added amygdalin standard in water extraction
at 37oC
112
Figure 4-1 Chromatogram of ethanol extract of apple seeds
obtained from reversed-phase HPLC
132
Figure 4-2 Extraction yield of amygdalin from juice made from apple
flesh with core and whole apple
138
Figure 4-3 Image of the juice extractor used for apple juice
production, showing disintegrated apple seeds left after
extraction of juice from one whole apple fruit
139
Figure 4-4 Amygdalin content of freshly made apple juice 142
Figure 4-5 Image of freshly-made apple juice from Braeburn apple, 143
xv
showing changes in colour of the juice after a few
minutes of holding
Figure 4-6 Effects of processing on whole apple juice produced
from different apple varieties
144
Figure 5-1 Functional groups (with numbers available) in bovine
serum albumin (BSA) 159
Figure 5-2 UV absorbance spectra of naringin and BSA 164
Figure 5-3 UV absorbance spectra of naringin-BSA conjugates 165
Figure 5-4 Graph of conjugation ratio of naringin: BSA 168
Figure 5-5 UV absorption spectra of amygdalin, BSA and
amygdalin-BSA conjugate from the periodate cleavage
method
171
Figure 5-6 UV absorption spectra of amygdalin, BSA and
amygdalin-BSA conjugate from the cyanuric chloride
method
172
Figure 5-7 TNBS standard curves obtained with BSA and
amygdalin-BSA conjugate from the periodate cleavage
method
175
Figure 5-8 TNBS standard curves obtained with BSA and
amygdalin-BSA conjugate from the cyanuric chloride
method
176
Figure 5-9 Non-competitive ELISA for polyclonal anti-amygdalin
antibody titre
178
Figure 5-10 Titre curves of anti-amygdalin antibody obtained from
rabbit 2 immunized with amygdalin-BSA conjugate from
the periodate cleavage method
179
Figure 5-11 Titre curves of anti-amygdalin antibody obtained from
rabbit 2 immunized with amygdalin-BSA conjugate from
the periodate cleavage method
180
Figure 5-12 Titre curves of anti-amygdalin antibody obtained from
rabbit 2 immunized with amygdalin-BSA conjugate from
182
xvi
the cyanuric chloride method
Figure 5-13 Titre curves of anti-amygdalin antibody obtained from
rabbit 2 immunized with amygdalin-BSA conjugate from
the cyanuric chloride method
183
Figure 5-14 Standard curve of amygdalin obtained from polyclonal
antibody produced from the periodate cleavage method
185
Figure 5-15 Standard curve of amygdalin obtained from polyclonal
antibody produced from the periodate cleavage method
186
Figure 5-16 Standard curve of amygdalin obtained from the changed
ELISA procedure using 1% BSA-PBST as buffer for both
amygdalin standard and antibody dilutions
186
Figure 5-17 Standard curve of amygdalin obtained from the changed
ELISA procedure using 1% BSA-PBST as buffer for both
amygdalin standard and antibody dilutions
187
Figure 5-18 Standard curve of amygdalin obtained from the
changed ELISA procedure
187
Figure 5-19 Standard curve of amygdalin obtained from the changed
ELISA procedure
188
Figure 5-20 Competitive ELISA standard curve of amygdalin
obtained from antibody generated from the cyanuric
chloride conjugate, showing the binding of the antibody
to the free amygdalin standard
190
Figure 5-21 Competitive ELISA standard curve of amygdalin
obtained from antibody generated from the cyanuric
chloride conjugate, showing no inhibition of antibody
binding by free amygdalin standard
191
Figure 6-1 Mean standard curve for the indirect competitive ELISA
for amygdalin derived from 20 different curves
209
Figure 6-2 Cross-reaction of the polyconal anti-amygdalin antibody
with other cyanogenic glycosides that are structurally
related to amygdalin
212
xvii
Figure 6-3 ELISA standard curve obtained by preparing amygdalin
in assay buffer and apple cider extract diluted in assay
buffer
214
Figure 6-4 Linearity of the ELISA assay response with apricot
kernel extract
215
Figure 6-5 Analysis of amygdalin in food products using the
icELISA and an HPLC method
217
Figure 7-1 Summary of the research study 226
xviii
List of tables
Table 1-1 Chemical protection strategies of plant secondary
metabolites
2
Table 1-2 Source of some plant toxins and their harmful effect 6
Table 1-3 The chemical structure of some cyanogenic glycosides
and their sugar moiety
10
Table 1-4 Major cyanogenic glycosides of food plants and their
cyanogenic potential
11
Table 1-5 Clinical manifestation of the toxic effect of cyanide 21
Table 1-6 Cyanide-induced disease observed in particular
countries
24
Table 1-7 Toxic level of cyanogenic glycosides in food 27
Table 1-8 Enzymes commonly used as labels for EIA 37
Table 3-1 Sensitivity of some analytical methods available for
detecting amygdalin
98
Table 3-2 Recovery (%) of amygdalin from spiked almond
kernels
112
Table 3-3 Amygdalin content of kernels 116
Table 3-4 Amygdalin content of seeds 117
Table 3-5 Amygdalin content of processed products 119
Table 4-1 Recovery (%) of amygdalin from spiked apple seed
samples
133
Table 4-2 Amygdalin content of apple seeds from different
varieties of apple
135
Table 4-3 Amygdalin content of commercially-available apple
juices from pressed/squeezed apples
146
Table 4-4 Amygdalin content of commercially-available long-life
apple juices
147
Table 5-1 The initial conjugation ratio and the final conjugation
ratio of naringin in naringin-BSA conjugate
167
xix
Table 6-1 Effect of antibody dilution, incubation time, coating
antigen concentration and protein buffers on ELISA
sensitivity
208
Table 6-2 Cross-reaction data for amygdalin and other four
structurally related cyanogenic glycosides
211
Table 6-3 Analysis of amygdalin in food products 216
xx
Abbreviations
ADP Adenosine diphosphate
ATP Adenosine triphosphate
B-cell Bone marrow lymphocytes
Bp Boiling point
BSA Bovine serum albumin
CC Cyanuric chloride
DNA Deoxyribonucleic acid
EIA Enzyme immunoassay
ELISA Enzyme-linked immunosorbent assay
ELSD Evaporative light scattering detector
Fe Iron
GCMS Gas chromatography-mass spectrometry
HCN Hydrogen cyanide
IgG Immunoglobulin G
IRMA Immunoradiometric assay
KLH Keyhole limpet hemocyanin
LOD Limit of detection
LOQ Limit of quantification
M Moles per litre
MHC Major histocompatibility complex
mRNA Messenger Ribonucleic acid
OVA Ovalbumin
PAD Pulsed amperometric detector
PBST Phosphate buffered saline with tween 20
PCR Polymerase chain reaction
RIA Radioimmunoassay
RP-HPLC Reversed-phase high performance liquid chromatography
ScFv Single-chain variable fragment
TMB 3, 3’, 5, 5’- Tetramethyl benzidine
xxi
TNBS Trinitrobenzene sulfonic acid
UHT Ultra-heat treated
UV Ultraviolet
VH Heavy chain variable region
VL Light chain variable region
v/v Volume to volume ratio
w/v Weight to volume ratio
Chapter 1: Introduction
1
Chapter 1
Introduction
1.1 Plant toxins
Plant toxins are naturally-occurring secondary metabolites that may be
poisonous to pathogens, herbivores and humans. They protect plants from
predators by acting as chemical defense compounds against herbivores,
insects and pathogens (Table 1-1). They usually behave by altering specific
mechanisms involving enzymes, receptors and genetic targets in particular
cells and tissues (Wink, 1988). They may be present in the whole plant or in
seeds, fruits, leaves or stalks. Depending on plant species, the poisonous
constituent may be concentrated in one or more parts of the plants or it may
be present throughout the plant (Chandra et al., 2012). According to a
review by Wittstock and Gershenzon (2002), plant parts that are of high risk
of attack by herbivores or other predators tend to accumulate high levels of
toxic compounds compared to the parts that are rarely attacked. Although
not all plant secondary metabolites are toxins, this study focused on the
secondary metabolites that are toxins. The toxins are toxic to humans,
animals and insects when they come in contact with them either internally or
externally. Plant toxins such as hypericin are also used as signals to control
physiological responses to attack (Kliebenstein, 2012).
Plant toxins are classified based on their structural and chemical
constituents: alkaloids, glycosides, proteins, oxalates, anti-vitamins, tannins,
volatile ethers, phytoestrogens, terpenes, glucosinolates and
Chapter 1: Introduction
2
phenylpropanoids (Wink, 1988; Chandra et al., 2012). Structures of
examples of plant toxins are shown in Figure 1-1.
Table 1-1: Chemical protection strategies of plant secondarymetabolites
Compound Biological activity
Alkaloids Toxic for vertebrates, arthropods,
bacteria
Cyanogenic glucosides Toxic for animals
Flavonoids/anthocyanins Antimicrobial, insectistatic
Glucosinolates Repellant for animals, antimicrobial
Non-protein amino acids Toxic for animals, antimicrobial
Phenylpropanoids Antimicrobial
Terpenes Repellent for animals, antimicrobial
(Adapted from Wink, 1988)
Chapter 1: Introduction
3
Anisatin (found in Japanese anise plant)
Coumestrol (found in alfalfa, red clover and
soybeans)Hypericin (found in St John’s wort
plant)
Cicutoxin (found in western water-hemlock)
Oleandrin (found in nerium oleander and Laurier rose plant)
Pyrrolizidine (found in the leaves of
tobacco and carrot)
Figure 1-1: Structures of example plant toxins
Chapter 1: Introduction
4
Examples of specific natural plant toxins from each class of plant toxin are
listed below;
(i) Plant toxins categorised based on the chemistry of the compounds;
Nitrile containing compounds;
Alkanenitriles e.g. cyanaogenic glycosides.
α, β-unsaturated nitriles e.g. samentosin.
Aromatic nitriles e.g. Cytotoxin (Fleming, 1999).
Sulfur containing compounds e.g glucosinolate (Halkier &
Gershenzon, 2006).
C17 conjugated polyacetylene compounds e.g. cicutoxin,
oenanthotoxin (Schep et al., 2009).
Glucoside of methylazoxymethanol e.g. cycasin (Wogan &
Busby, 1980).
Ester derivatives of 1-hydroxymethyl-1, 2-dehydropyrrolizidine
e.g. pyrrolizidine alkaloids (Wogan & Busby, 1980).
(ii) Plant toxins categorized based on their toxic effect;
Carcinogens e.g. pyrrolizidine alkaloids, cycasin (Wogan &
Bussy, 1980).
Those that inhibit cellular respiration e.g. cyanogenic
glycosides (Wajant & Mundry, 1994; Hamel, 2011).
Those that discrupt cellular membranes e.g. saponin (Osbourn
, 1996).
Chapter 1: Introduction
5
Central nervous system stimulatory effect (including seizures)
e.g. cicutoxin, oenanthotoxin (Schep et al., 2009).
Growth inhibitor e.g. glucosinolate (Ulmer et al., 2001).
Several plant species are cultivated for food and many plants or plant parts
(seeds, leaves, fruits) are consumed as food. Seeds are important food
sources for animals including humans because of their high nutrient contents
(starch, protein, lipids, fibre, vitamins and minerals). Leaves and fruits are
good sources of vitamins and minerals for humans. Although animals
including humans depend on plants for sustenance, plant foods contain quite
a large numbers of naturally-occurring toxins that are harmful to both
animals and humans. Table 1-2 shows examples of plant toxins and their
harmful effects.
Chapter 1: Introduction
6
Table 1-2: Source of some plant toxins and their harmful effects
Plant name Plant part Toxin Harmful effect
Black locust Bark, seeds Glycoprotein-abrin, ricin,lectin
Constipation,diarrhea, muscleweakness, ataxia
Buckwheat Whole plantexcept ripeseeds
Fagopyrin,dianthroquinones
Photosensitization,sloughing of skin
Castor bean Seeds Ricin, lectin Diarrhea,depression,anorexia, bloat
Choke cherry Wilted leaves Cyanogenic glycosides-prunasin, amygdalin
Increasedsalivation,nervousness
Crotolaria Whole plant Pyrrolizidine alkaloids Weight loss,depression
Lupin Whole plant Quinazolidine alkaloids,anagyrine
Teratogenic,respiratory failure
Potato Foliage Glycolalkaloids-solanine Diarrhea,abdominal cramps,headache
Rhubarb Whole plant Oxalic acid Nephrotoxic
Rosary pea Whole plant Abrin Photosensitivity,vomiting,convulsiveseizures,pulmonary edema
Sweet pea Whole plant Glycosides Diarrhea,abdominal cramps,headache
Tobacco Whole plant Nicotine, anabasine Teratogenic
(Adapted from Chandra et al., 2012)
Chapter 1: Introduction
7
1.1.1 Cyanogenic glycosides
Cyanogenic glycosides are the most important defense-related secondary
metabolites and class of natural plant toxin in plant foods. Cyanogenic
glycosides are plant toxins that consist of α-hydroxinitrile aglycones and a
sugar moiety (Vetter, 2000). They are widely distributed in the plant
kingdom, being present in more than 2,500 species (Ganjewala et al., 2010).
The structure of some cyanogenic glycosides and their sugar moiety is
shown in Table 1-3. Cyanogenic glycosides are common in certain families
such as the Fabaceae, Rosaceae, Leguminoseae, Linaceae and
Compositae and identification of their constituents’ is a useful tool for
informative taxonomic markers (Vetter, 2000). Many studies have shown the
efficiency of cyanogenic glycosides as defence agents in nature. For
example, feeding experiments conducted by Ballhorn et al. (2009) showed
that when two natural insect herbivores of lima bean (Gynandrobrotica
guerreroensis and Cerotoma ruficornis) were fed with high cyanide-
containing leaves and low cyanide leaves, the total leaf consumption was
low (15%) when the insects were provided with high cyanide leaves
compared to when low cyanide leaves (total leaf consumption was 85%)
were available for their consumption, thus indicating the high repellent
activity of high cyanogenic potential to herbivores. In another study by
Tattersall et al. (2001), when the pathway for the biosynthesis of the
cyanogenic glycoside dhurrin was transferred from sorghum into an
acyanogenic plant (Arabidopsis thaliana), the transgenic Arabidopsis
thaliana had resistance to flea beetle conferred upon it.
Chapter 1: Introduction
8
In addition to their defence function in plants, cyanogenic glycosides have
been reported to serve important functions in primary metabolism. According
to Moller (2010), a high concentration of cyanogenic glycosides in seeds
during germination may serve to provide aspartate or asparagines for
transmination reactions required to balance amino acid supply to the
developing seedling. Cyanogenic glycosides have been reported to serve as
storage forms for reduced nitrogen (Poulton, 1990).
Several thousand plant species, including economically important food
plants, synthesize cyanogenic glycosides; linamarin in cassava and butter
bean, dhurrin in sorghum and macadamia nut, amygdalins in almond, peach,
sweet cherry and sour cherry (Jones, 1998; Vetter, 2000; Donald, 2008).
The level of cyanogenic glycosides in plants depends on the age and variety
of the plant as well as environmental factors. For instance, cassava crops
grown in low altitude areas have been reported to contain high levels of
cyanogenic glycosides while those grown in high altitude areas contain low
levels of cyanogenic glycosides (Oluwole et al., 2007). Although most plants
produce small amounts of cyanide, more than 300,000 plants produce
different secondary metabolites including cyanogenic glycosides
(Zagrobelny et al., 2008). Levels of cyanogenic glycosides in different parts
of the plants vary and also vary between the same parts of different
individual plants of the same species. While high concentrations of
cyanogenic glycosides are usually found in plant leaves, cyanogenic
Chapter 1: Introduction
9
glycosides may also be concentrated in plant roots, seeds or other plant
tissues (Seigler, 1975). Table 1-4 lists the major cyanogenic glycosides of
food plants and their cyanogenic potential.
The occurrence of cyanogenic glycosides in food and fodder can be a
significant social and economic problem in many parts of the world. In Africa,
dietary use of cassava (Manihot esculenta Crantz) has been associated with
cyanide poisoning, tropical neuropathy disease and konzo (Tylleskär et al.,
1992; Mlingi et al., 1992; Teles, 2002; Ernesto et al., 2002). In 1992, cyanide
from cyanogenic glycosides of cassava was responsible for the death of
three people in Nigeria (Alade and Tunwashe, 1992). Recently, five
Nigerians apparently died of cyanide poison after eating a meal prepared
with cassava flour (Makinde, 2010).
Despite the toxicity of cyanogenic glycosides, farmers continue to grow
crops with high levels of cyanogenic glycosides, because they act as natural
pesticides to protect crops against animal pests.
Chapter 1: Introduction
10
Table 1-3: The chemical structure of some cyanogenic glycosides and
their sugar moiety
Configuration Glycoside Sugar
Linamarin
Lotaustralin
Dhurrin
Prunasin
Amygdalin
Taxiphyllin
Triglochinin
D-glucose
D-glucose
D-glucose
D-glucose
Gentiobiose
D-glucose
D-glucose
Chapter 1: Introduction
11
Table 1-4: Major cyanogenic glycosides of food plants and their
cyanogenic potential
Food Major cyanogenic
glycosides present
Potential forCyanide generation(mg HCN/kg)
Cassava (Manihot esculenta) –
root
Linamarin 15-1000
Sorghum (Sorghum vulgare) –
leaves
Dhurrin 750-790
Flax (Linum usitatissimum) -
seed meal
Linamarin, linustatin,
neolinustatin
360-390
Lima beans (Phaseolus
lunatus)
Linamarin, lotaustralin 2000-3000
Giant taro (Alocasia
macrorrhizos) - leaves
Triglochinin 29-32
Bamboo (Bambusa
arundinacea) - young shoots
Taxiphyllin 100-8000
(Haque & Bradbury, 2002; Simeonova & Fishbein, 2004).
1.1.1.1 Biosynthesis of cyanogenic glycosides
Cyanogenic glycosides are derived from five amino acids; valine, isoleucine,
leucine, phenylalanine and tyrosine, and from the non-proteinogenic amino
acid, cyclopentenyl glycine. For example, linamarin and lotaustralin are
derived from valine, isoleucine and leucine, dhurrin is derived from tyrosine,
and amygdalin and prunasin are derived from phenylalanine (Seigler, 1975;
Conn, 1979). Several authors have described the biosynthesis of
cyanogenic glycosides in different plants. For instance the biosynthesis of
Chapter 1: Introduction
12
the tyrosine-derived cyanogenic glycosides dhurrin has been described
extensively in sorghum and other plants such as seaside arrow grass,
cassava and barley (as reviewed by Ganjewala et al., 2010).
The biosynthetic pathway of cyanogenic glycosides is illustrated in Figure 1-
2. The first and the second steps of cyanogenic glycoside biosynthesis are
catalysed by a cytochrome P450 through two successive N-hydroxylations of
the amino group of the parent amino acid, followed by decarboxylation and
dehydration; α-hydroxynitrile is produced from the action of a second
cytochrome P450 on the aldoxime (Kahn et al., 1997; Bak et al., 1998).
Hydroxynitrile (also known as cyanohydrin) is generated following an initial
dehydration reaction to form a nitrile through the hydroxylation of the alpha
carbon and glycosylation of the cyanohydrin moiety (the final step in
cyanogenic glycoside synthesis) is catalysed by UDPG-glycosyltransferase
(Jones et al., 1999).
Figure 1-2: The biosynthetic pathway for cyanogenic glycosides from its
precursor amino acid.
Chapter 1: Introduction
13
1.1.1.2 Cyanogenesis
Cyanogenesis is the ability of plants and other living organisms to release
hydrogen cyanide (Poulton, 1990; White et al., 1998; Zagrobelny et al.,
2008; Ballhorn et al., 2009). Although cyanogenic glycosides are not toxic
when intact, enzymic action on cyanogenic plants causes release of
hydrogen cyanide causing potential toxicity issues for animals including
humans. While cyanogenic glycosides are stored in vacuoles within the cell,
the enzymes are stored in the cytoplasm. When the plant tissues are
disrupted by herbivores or during processing, toxic hydrogen cyanide could
be released from the hydrolysis of cyanogenic glycosides by plant
endogeneous enzymes; β-glucosidase and α-hydroxynitrile lyases
(Zagrobelny et al., 2004).
In plants, cyanogenic glycosides serve as important chemical defense
against herbivores due to their ability to generate hydrogen cyanide
(Zagrobelny et al., 2004; Ganjewala et al., 2010). In humans, consumption of
cyanogenic plants could cause acute cyanide poisoning with associated
symptoms including; anxiety, headache, dizziness, confusion, decreased
consciousness, hypotension, paralysis and coma. Cases of cyanide
poisoning are common from the consumption of plants of Rosaceae (peach,
apricot, plum, apple seed), Leguminosae (Lima beans, broad beans),
Euphorbiaceae (cassava) or members of the genus Sorghum (Jones, 1998;
Francisco & Pinotti, 2000; Vetter, 2000). Indeed, incidents of acute cyanide
poisoning have been reported from Literature. For instance, a woman was
Chapter 1: Introduction
14
affected with cyanide poisoning after ingesting apricot kertnels (Suchard et
al., 1998), thirteen people were also reported to be intoxicated with cyanide
after eaten apricot seeds (Akyildiz, 2010). A case of a girl who became
unconscious after eaten apricot kernels was reported by Sahin (2011). In
another report, an elderly woman was affected with cyanide poisoning after
ingesting bitter almonds (Sanchez-Verlaan et al., 2011), three people were
also affected with cyanide posoining after consuming a cassava based meal
(Akintonwa & Tunwashe, 1992).
1.1.1.3 Enzymatic hydrolysis of cyanogenic glycosides in food
plants
Enzyme activity results in cleavage of the carbohydrate moiety of the
cyanogenic glycoside to yield corresponding cyanohydrins which further
decompose to release hydrogen cyanide and an aldehyde or ketone
(Poulton, 1990).
In cassava, the cyanogenic glycosides linamarin (α-hydroxybutyronitrile-β-D-
glucopyranoside) and lotaustraulin (ethyl linamarin) are located in the plant
vacuoles and the enzyme is located in the cell wall (Gruhnert et al., 1994).
Hydrolysis of linamarin from cassava starts from the disintegration of the root
tissue during processing or chewing to release the endogenous enzyme
(linamarase) that hydrolyses linamarin to glucose and acetone cyanohydrins
(which are unstable in neutral/alkaline solution). During processing, reduced
Chapter 1: Introduction
15
moisture and/or increased temperature facilitate the spontaneous
breakdown of cyanohydrins to toxic hydrogen cyanide (McMahon, 1995).
In sorghum, the cyanogenic glycoside dhurrin (4-hydroxymandelonitrile-β-D-
glucopyranoside) is stored in the plant vacuoles (separated from the
enzymes). When the plant tissue is crushed, the enzymes and dhurrin are
brought in contact and hydrolysis is initiated by β-glucosidase (dhurrinase)
which hydrolyzes the cyanogenic glycoside to form hydroxymandelonitrile
and glucose. Hydroxymandelonitrile further decomposes spontaneously or
enzymatically by the action of hydroxynitrile lyase to form hydrogen cyanide
and hydroxybenzaldehyde (Wajant & Mundry, 1994). Enzymatic hydrolysis
of linamarin and dhurrin is illustrated in Figure 1-3.
Amygdalin (D-mandelonitrile-β-D-gentiobioside) is one of the most common
cyanogenic glycosides. It can be found in plant families of the
Caprifoliaceae, Mimosaceaw, Oleaceae and Rosaceae (Vetter, 2000) and is
present in kernels and seeds of fruits such as apples, apricots, almonds,
cherries, plums and peaches (Donald, 2009). Amygdalin and prunasin (D-
mandelonitrile-β-D-glucopyranoside) are degraded by endogenous enzymes
(β-glucosidases) to form non-glycosidic cyanogen molecules; mandelonitrile
and free (CN-) cyanide ion (Tunçel et al., 1998). Enzymatic degradation of
amygdalin is divided into three parts. The first part involves the splitting of
amygdalin to prunasin and glucose by the enzyme amygdalin lyase. The
second part is the hydrolysis of prunasin to mandelonitrile and glucose by
Chapter 1: Introduction
16
the enzyme prunasin lyase and the final stage of the hydrolysis is the
breaking down of mandelonitrile to benzaldehyde and hydrogen cyanide
(HCN) by hydroxynitrile lyase (Haisman & Knight, 1967). Enzymatic
hydrolysis of amygdalin is illustrated in Figure 1-4.
Chapter 1: Introduction
17
Linamarase
Spontaneous/Hydroxynitrile lyase
AcetoneHydrogen
cyanide
Linamarin
Acetone cyanohydrin
Glucose
Dhurrin
Dhurrinase
Glucose Hydroxymandelonitrile
Hydroxynitrilelyase
Figure 1-3: The structures and hydrolytic products of linamarin and dhurrin.
Hydroxybenzaldehyde
Chapter 1: Introduction
18
OH
CN
C
H
OH
CN
C
H
Figure 1-4: Enzymatic hydrolysis of amygdalin and prunasin to form
hydrogen cyanide. (A) Splitting of amygdalin to prunasin and glucose by
the enzyme amygdalin lyase, (B) The breakingdown of prunasin to
mandelonitrile and glucose by the enzyme prunasin lyase, (C) the hydrolysis
of mandelonitrile to benzaldehyde and hydrogen cyanide.
1.1.1.4 Mechanism of cyanide poisoning
Cyanide is a highly fatal and rapidly acting poison. The toxicity of cyanide is
largely attributed to cessation of aerobic cell metabolism. Cyanide causes
intracellular hypoxia by reversibly binding to the cytochrome oxidase a3
(which is necessary for the reduction of oxygen to water in oxidative
phosphorylation) within the mitochondria. Binding of cyanide to ferric ion in
+ HCN
(A)
(B)
(C)
+ Glucose
Amygdalin Prunasin
Prunasin Mandelonitrile
Mandelonitrile Benzaldehyde
+ Glucose
Chapter 1: Introduction
19
cytochrome oxidase a3 inhibits the terminal enzyme in the respiratory chain
and halts electron transport and oxidative phosphorylation (which is
essential to the synthesis of adenosine triphosphate (ATP) and the
continuation of cellular respiration (Beasley & Glass 1998; Hamel, 2011).
The exposure of humans or animals to hydrogen cyanide either through the
skin, eye or oral ingestion results in absorption and distribution of cyanide in
the blood, and subsequent binding of hydrogen cyanide with Fe2+ of the
hemoglobin to form cyanohemoglobin. Cyanide also binds to Fe3+/Fe2+ of
cytochrome oxidase enzyme (present in the mitochondria cell), inactivating
the enzyme and causing a reduction in oxygen utilization by the body
tissues. This may result in cytotoxic hypoxia, a shift from aerobic metabolism
to anaerobic metabolism (because of decrease in the ATP/ADP ratio) and an
increase in the levels of glucose and lactic acid in the blood. Cyanide also
inhibits the tricarboxylic acid cycle by decreasing the rate of glycolysis and
activating glycogenolysis, thus causing a reduction in energy available to the
respiratory system, the heart and other cells (Speijers, 1993). Although
toxicity of cyanide can develop over minutes or hours after exposure,
exposure to high concentrations of cyanide can cause instant death.
Chapter 1: Introduction
20
1.1.1.5 Clinical manifestation of cyanide poisoning
The acute lethal dose for cyanide after oral ingestion in humans is in the
range of 0.5 to 3.5mg/kg body weight (Speijers, 1993). The onset of signs
and symptoms of cyanide poisoning is usually less than 1 minute after
inhalation and within a few minutes after ingestion (Hamel, 2011). The
clinical features of acute cyanide poisoning are variable (Table 1-5). The
major determinants of severity and mortality are the source of exposure, the
route and the magnitude of exposure and the effects and the time taken for
any treatments that may have been tried (Yen et al., 1995).
1.1.1.6 Treatment of cyanide poisoning
Cyanide poisoning is treatable when quickly recognised and immediately
countered with an antidote. An ideal cyanide antidote would act rapidly and
effectively with little to no treatment-limiting adverse effect. Currently,
treatment of cyanide poisoning involves the use of a cyanide antidote kit
(amyl nitrite + sodium nitrite + thiosulfate) or hydroxocobalamin (Borron,
2006). Cyanide antidote kit provides an effective treatment when combined
with supportive treatment such as a 100% O2 ventilator, vasopressors and
sodium bicarbonate (Yen et al., 1995). Hydroxocobalamin (Vitamin B12a)
detoxifies cyanide by binding with it to form the renally excreted, non-toxic
cyanocobalamin or Vitamin B12. Because it binds without forming
methemoglobin, hydroxocobalamin can be used to treat patients without
compromising the oxygen carrying capacity of haemoglobin. The antidotal
effect is enhanced by thiosulphate. Hydroxocobalamin antidote is safer in
Chapter 1: Introduction
21
patients who have pre-existing hypotention or are pregnant (Beasley &
Glass 1998; Hamel, 2011).
Table 1-5: Clinical manifestation of the toxic effects of cyanide
System Manifestation
Central nervous Anxiety
Headache
Giddiness
Dizziness
Confusion
Mydriasis
Bright retinal veins
Decreased consciousness
Seizures
Paralysis
Coma
Respiratory Hyperventilation and tachypnea (due to hypoxic
stimulation of peripheral and central chemoreceptor)
Absence of cyanosis (caused by an increased in
oxygen content in venous blood)
Hypoventilation
Apnea (cells cannot take up oxygen)
Cardiovascular Trachycardia
Hypotension
Supraventricular tachycardia
Artrioventricular blocks
Ventricular fibrillation
Asystole
(Adapted from Hamel, 2011).
Chapter 1: Introduction
22
1.1.1.7 Human health effect of cyanogenic glycosides
The potential toxicity of food produced from cyanogenic plants depends on
the likelihood that consumption could result in concentrations of hydrogen
cyanide (HCN) that are toxic to exposed humans or animals. The lethal dose
of orally ingested hydrogen cyanide for a 60kg adult man ranges from 30-
210 mg equivalent HCN (Nhassico et al., 2008). Chronic cyanide exposure
associated with the consumption of insufficiently processed bitter cassava
(in regions of the world where cassava is the major source of dietary
energy), almond kernels and apricot seeds have been associated with a
number of cyanide-induced disorders including:
i. Cyanide poisoning: occurs as a result of consumption of bitter
cassava, almond kernels or apricot kernels and their products
without proper processing. The clinical symptoms are vomiting,
nausea, dizziness, stomach pains, weakness, headache, diarrhea
and occasionally death (Lasch & Shawa, 1981; Mlingi et al., 1992;
Kwok, 2008; Akyildiz et al., 2010; Sanchez-Verlaan et al., 2011).
ii. Tropical ataxic neuropathy (TAN): occurs in older people due to a
monotonous consumption of cyanogenic glycosides from a bitter
cassava diet for many years, resulting in chronic thiamine
deficiency from inactivation of thiamine by the cyanogenic
glycosides (Adamolekun, 2010a). The disease is characterized by
unsteady walking, loss of sensation in the hands and feet,
blindness, deafness and weakness (CCDN, 2008).
Chapter 1: Introduction
23
iii. Konzo: an upper motor neurone disease of acute onset due to
continuous large intake of cyanogenic glycosides from
insufficiently processed bitter cassava, also resulting in thiamine
deficiency from inactivation of thiamine when the sulfur in thiamine
is utilized for detoxification of cyanide in the human body, thereby
causing an irreversible paralysis of the lower limbs in children and
women of child-bearing age (Tylleskär et al., 1992; Ernesto et al.,
2002; Adamolekun, 2010b).
iv. Goitre: results from interference by thiocyanate (the end product of
cyanide detoxification in the human body) in iodine metabolism,
leading to dietary iodine deficiency and associated disorders
(Gbadebo & Oyesanya, 2005). Table 1-6 shows the different parts
of the world where cyanide-induced disease are prominent.
Chapter 1: Introduction
24
Table 1-6: Cyanide-induced disease observed in particular
Countries
Country Food Disorder
Jamaica Cassava, Lima beans Peripheral neuritis
Nigeria Cassava Goitre, tropical ataxic
neuropathy, cyanide
poisoning
Mozambique Cassava Severe paralyzing illness
(konzo)
Zaire Cassava Goitre
Turkey Apricot kernels Cyanide poisoning
Israel Apricot kernels Cyanide poisoning
France Almond seeds Cyanide poisoning
(Lasch & Shawa, 1981; Jones, 1998; Akyildiz et al., 2010; Sanchez-Verlaan et al., 2011).
1.1.1.8 Mechanism of cyanide detoxication in human
Cyanide is detoxified by the enzyme rhodanase (a sulfur transferase enzyme
present in the liver) with the help of sulfur donors, such as sulfur-containing
amino acids (cysteine and methionine) or their products of metabolism, to
thiocyanate which is excreted in the urine with very little in the faeces (Oke,
1973). When hydrogen cyanide is converted to thiocyanic acid, there is a
200-fold reduction in toxicity. However, the detoxication mechanism in the
Chapter 1: Introduction
25
body will only cope with minutes amount of cyanide generated from the
consumption of small amounts of cyanogenic plants, but not with a toxic
amount or a large dose of cyanide introduced artificially to the body.
Another important independent pathway for cyanide detoxication is
cyanocobalamin (vitamin B12). Cyanocobalamin occurs in the liver to some
extent as the hyroxocobalamin (vitamin B12a), which is capable of reacting
with cyanide to form cyanocobalamin. Cyanide detoxication also occurs to a
lesser extent by mercaptopyruvate (cyanide sulfur transferase) (Oke, 1973).
The major substrates for this conversion are thiosulfate and 3-
mercaptopyruvate. 3-mercaptopyruvic acid can arise from cysteine via
transamination or deamination and this compound can provide sulfur as
rapidly as thiosulfate for cyanide detoxification (Figure 1-5).
Although the human body is protected against cyanide toxicity through
detoxification of ingested cyanogenic glycosides by rhodanase, the amount
of cysteine and methionine in the diet is a contributing factor to cyanide-
induced disease as sulfur-containing amino acids are required for the
detoxification process. The high consumption of cyanogenic plants and their
products can therefore result in the depletion of essential amino acids and in
thiamine deficiency when the diet is short of protein and thiamine (Rosling,
1994; Padmaja, 1996; Ngudi et al., 2002; Ademolekun, 2010b).
Chapter 1: Introduction
26
L-CysteinSHCH2CH(NH2)COOH
Figure 1-5: The reaction of cyanide with 3-mercaptopyruvate to form
sulfur and thiosulfate.
1.1.1.9 Toxicity of cyanogenic glycosides
Toxicity of amygdalin and linamarin are associated with free cyanide, toxic
levels of cyanogenic glycosides are therefore estimated in terms of the
amount of hydrogen cyanide liberated. Data on the concentration of
cyanides in the total diet are lacking (WHO, 2004), and as a result there is
inconsistencies in the toxic levels of amygdalin and linamarin reported in
literatures (Table 1-7).
Safe level of intake of cyanogenic glycosides could not be estimated
because of lack of quantitative toxicological and epidermiological
information. However, world health organisation (FAO/WHO, 1991)
transamination3-mercaptopyruvateSHCH3COCOOH
Sulfur transferenceS2O3
2- + pyruvateCH3COCOOH
CN- Sulfurtransference
SOH- + pyruvate
rhodaneseOH-
SO2-2 + SCN
Chapter 1: Introduction
27
concluded that a level of up to 10mg/kg HCN in cassava flour is not
associated with acute toxicity.
Table 1-7: Toxic level of cyanogenic glycosides in food
Cyanogenic compound Toxic level (mg
HCN/kg)
Reference
Amygdalin
65 Humbert et al., 1977
340 Sadoff et al., 1978
9 – 59 Solomonson, 1981
74 Shragg et al., 1983
50 Holzbecher et al., 1984
Linamarin
100 – 2000 Oke, 1980
50 Osuntokun, 1981
14 – 30 Ministry of health
Mozambique, 1984
50 – 60 Speijers, 1993
The increased in belief of complementary or alternative treatment for cancer
has led to the use of amygdalin or laetrile for cancer treatment. However,
according to the study conducted by national cancer institute in 1982 which
involve 175 cancer patients. The trial found out that tumor size had
increased in all patients that were treated with amygdalin/laetrile and that
minimal side effects were observed except in two patients who consumed
bitter almonds instead of amygdalin/laetrile and suffered from cyanide
Chapter 1: Introduction
28
poisoning (NCI, 2013). Nevertheless, the consumption of sweet almonds
seeds have been reported to prevent cancer development in healthy people
(Edgar Cayce’s, 2013).
1.1.1.10 Prevention of cyanide-induced disease
Cyanide-induced disease can be prevented by effective removal of
cyanogenic compounds in food plants prior to consumption. Cyanogenic
plants are subjected to various processing methods such as cooking;
steaming, boiling, roasting, baking and other processes such as peeling,
soaking, grating, fermentation and sun drying, to reduce their cyanide
content to safe levels (Kemdirim et al., 1995; Tunςel et al., 1995; Obilie et
al., 2004; Cardoso et al., 2005; Perera, 2010). In eastern and southern
Africa, cassava is processed into flour, which is produced by sun drying of
the peeled root followed by pounding and sieving or heap fermentation,
however, because this process does not allow enough contact between
linamarase and linamarin, the product may contain up to 59ppm of HCN
equivalents, compared to the WHO safe level of 10ppm (Montagnac et al.,
2009).
In western Africa and southern America, cassava parenchyma is ground,
grated or crushed into small pieces to disrupt many plant cells and allow
good contact between linamarin and linamarase. The moist mash is then left
to ferment for several days, the water-soluble cyanogens squeezed out and
the residual HCN gas is removed by roasting. This process reduced the
Chapter 1: Introduction
29
cyanogen content of the product (gari or farinha) significantly (Montagnac et
al., 2009).
Recently, a new processing method that reduced the total cyanide content of
cassava by three to six-fold of its former value (i.e from 43ppm to 7ppm) was
developed by Bradbury & Denton (2007). The method involved mixing dry
cassava flour with water and spreading it on a thin layer in the shade for five
hours or in the sun for two hours (prior to cooking the cassava flour) to allow
the catalytic breakdown of linamarin to hydrogen cyanide.
Adequately processed cyanogenic plants, effective detection methods for
residual cyanogens in processed products and use of plant cultivars with low
level of cyanogen content will reduce and help to maintain safe level of
cyanogenic glycoside contents of cassava-based foods and other
cyanogenic plants to 10ppm; the safe level of cyanide recommended by
world health organization (McMahon et al., 1995; Adamolekun, 2010b).
1.1.1.11 Analysis of cyanogenic glycosides
Traditionally, the cyanogenic glycosides in food plants are quantified in
terms of total cyanide released after acid or enzymatic hydrolysis of
cyanogenic plant rather than the glycoside content itself. Although this
quantification does not give reliable and reproducible data because of the
difficulty involved in the isolation and recovery of cyanide from digested
Chapter 1: Introduction
30
samples (which arises as a result of the volatility of hydrogen cyanide
(boiling point of 26oC). In addition, discrepancies occur in acid hydrolysis
due to the formation of amides and ammonia while in spontaneous autolysis
by enzymes, the activity of enzymes is influenced by the conditions
prevailing in the heterogeneous plant substrate, the accompany secondary
reactions and the accumulation of products of hydrolysis (Zitnak, 1973).
Nevertheless, the method has been used for the determination of the
cyanogen potential of different plants such as cassava roots and cassava
products (Cooke, 1978; Ikediobi et al., 1980; Bradbury et al., 1991; Yeoh &
Tan, 1994; Brimer et al., 1998; Djazuli & Bradbury, 1999), lima beans,
sorghum, wheat, millet, barley (Okafor, 2005) peach stone, apricot stone,
apple seed, giant taro, bamboo shoot (Haque & Bradbury, 2002) and
flaxseeds (Kobaisy et al., 1996).
Other numerous indirect quantitative methods have also been employed for
determination of cyanogenic glycosides in plants. These methods include
amperometric measurement with cyanide-sensitive electrode (Dalgaard &
Brimer, 1984), spectrophotometric estimation with alkaline picrate (Williams,
1979) or methemoglobin complex (Ajaelu et al., 2008), thin-layer
chromatography for a densitometric direct assay of cyanogenic glycosides
(Brimer et al., 1983), colorimetric methods (Tatsuma et al., 2000) and
alkaline picrate methods (Egan et al., 1998; Yeoh & Sun, 2001; Adindu et
al., 2003; Ngudi & Lambein, 2003). A resorcinol method which is based on
enzymatic hydrolysis of cyanogenic plants and trapping of hydrogen cyanide
Chapter 1: Introduction
31
in alkaline solution of resorcinol reagent followed by measuring the
absorbance at 488nm has also been developed (Drochioiu et al., 2008). This
method has been reported to be more sensitive than the picrate methods
(Drochioiu et al., 2008).
Recent research efforts for direct quantification of cyanogenic glycosides are
based on instrumental methods. Passion fruit cyanogenic glycosides
(amygdalin, prunasin and sabunigrin) were quantified by GC-MS
(Chassagne, 1996). A reversed phase chromatography with UV and pulsed
amperometric detection was developed by Wasserkrug & Rassi (1997) for
the detection of linamarin, amygdalin and prunasin and their degradation
products (mandelonitrile and benzaldehyde). An HPLC method with a
refractive index detector was developed for the determination of linamarin in
cassava root cortex (Sornyotha et al., 2007). Although, these methods are
sensitive, accurate and reproducible, they are expensive and time
consuming in terms of sample purification.
Despite the inherent sensitivity, simplicity, rapidity and cost effectiveness of
immunoassay methods, the use of immunoassay for quantitative
determination of cyanogenic glycosides in plant foods has not been
reported. Until now, there are only two reports on immunoassay
development for the qualitative analysis of amygdalin in food (Cho et al.,
2006; Cho et al., 2008).
Chapter 1: Introduction
32
1.2 Immunoassay
1.2.1 Definition
The term “immunoassay” generally refers to quantitative and characterizing
methods for analyzing the properties of the targets (sometimes analytes) of
antibody binding. Immunoassay has been one of the fastest-growing and
most widely used analytical techniques, and involves techniques for the
detection and quantification of antigens or antibodies (Edwards, 1996; Price
& Newman, 1997). Several variations exist in the design of particular
immunoassays. Generally, all assay names contain the word “immuno”
combined with another word indicating the type of label used, along with the
word “assay”. For example, in isotopic immunoassays, radioimmunoassays
(RIAs) described an assay system in which the detection label is a
radioisotope (Miles & Hales, 1968). RIA was first described in 1960 for
measurement of endogeneous plasma insulin in man by Yalow and Berson
(Yalow & Berson, 1960). In non-isotopic immunoassays, a variety of markers
or labels, individually or in combination, are used to follow and measure the
reactions. For example, enzyme immunoassays (EIAs), fluorescent
immunoassay, and chemiluminescent immunoassay (Voller et al., 1978;
Quan et al., 2006).
The word “immuno” and “metric” are used when the immunoassay involves
the use of reagents in stoichiometric excess. Thus, “immunometric assay” is
used to describe reagent excess assays (Deshpande, 1996). However,
depending on the label used, such an assay may be denoted as an
Chapter 1: Introduction
33
immunoradiometric assay (IRMA), immunoenzymometric assay or
immunofluorometric assay (Edwards, 1985; Hemmilä, 1985).
1.2.2 Enzyme-linked immunosorbent assay
The term “enzyme-linked immunosorbent assay” (ELISA), was first coined
and developed by Engvall & Perlmann (1971) and Van Weemen & Schuurs
(1971). ELISA is a term generally used for reagent-excess enzyme
immunoassays of specific antibodies or antigens. Enzyme immunoassay
(EIA) was developed as an alternative to radioimmunoassay. This is
because radioisotope-labeled reagents are unstable, hazardous to health,
and disposal of radioactive wastes is problematic. In contrast, enzymes used
in EIA are very stable and cause no health or waste disposal problems. In
addition, EIA can be as sensitive as radioimmunoassay, if not more so
(Engvall & Perlmann, 1972). The enzymes commonly used as labels in EIA
are described in Table 1-7.
There are two types of ELISA, namely; two-site ELISA (non-competitive
ELISA) and competitive ELISA. The two-site ELISA or non-competitive
ELISA is a sensitive and specific technique for quantifying molecules in
solution. The technique is based on the use of two antibodies. The two
antibodies recognize separate epitopes of the antigen to be measured and
thus bind to the antigen simultaneously. The immobilised antibody specific to
the substance to be measured is called the “capture” antibody. The capture
antibody is most commonly coated onto a high-capacity protein binding
Chapter 1: Introduction
34
microtitration plate wells. To prevent unspecific binding, any vacant binding
sites on the plate are sometimes blocked with the use of a protein such as
bovine serum albumin (BSA) or keyhole limpet hemocyanin (KLH). The
sample or standards are then incubated on the plate to allow the antigen to
bind to the capture antibody. The bound sample or standard can be detected
using a secondary antibody (which recognizes a different epitope on the
antigen) known as the detector antibody. The secondary antibody is usually
linked to an enzyme, and the addition of suitable substrate results in a
colorimetric reaction. The colour can be measured using a
spectrophotometer. The resulting optical density is proportional to the
amount of antigen present in the sample (Kemeny & Chantler, 1988; Jordan,
2005). A typical representation of the non-competitive ELISA technique is
shown in Figure 1-6.
Chapter 1: Introduction
35
Figure 1-6: Non-competitive ELISA assay showing the capture antibodies
and the detector antibodies (modified from Mabtech, 2010).
Competitive ELISA involves the use of two forms of the antigen; one the sample
antigen to be assayed and the other, a constant level of “tracer” or specific
antigen immobilized in the microtitration plate well. Plates are coated with the
specific antigen and these are then incubated with a mixture of antibody and the
test sample. If there is no antigen in the test sample the antibody becomes fixed
to the antigen sensitized surface. If there is antigen in the test solution this
combines with the antibody, which cannot then react with the sensitized solid
phase. The amount of antibody attached is then indicated by an enzyme labeled
antibody conjugate and enzyme substrate. The amount of inhibition of substrate
Capture antibody bound to surface
of microtitration plate
Antigen binds to capture antibody
Secondary antibody binds to antigen
Addition of substrate for colour
development
Optical density is proportional to the
amount of antigen in the sample
Chapter 1: Introduction
36
degradation in the test sample (as compared with the reference system) is
proportional to the amount of antigen in the test (Voller et al., 1978).
Competitive ELISA, unlike two-site ELISA, permits both simultaneous and
sequential incubation of sample and labeled antibody (Porstmann & Kiessig,
1992) and may be of greater specificity compared to the two-site ELISA
(Makarananda et al., 1995).
Chapter 1: Introduction
37
Enzyme Source pH(optimum)
Spectrumactivity(U/mg at
37oC)
Molecularweight
Chromogenicsubstrates andmeasurement
Alkalinephosphatase
Calf(intestine)
9-10 1,000 100,000 p-nitrophenyl-phosphateλ = 405nm (pNP)
β-galac -tosidase
E. coli 6-8 600 540,000 o-nitrophenyl-β-D-gala-ctopyranoside(oNPG)λ = 420nm
Chlorophenolic red-β-D- Galactopyranoside(CPRG)λ = 574nm
Peroxidase Horseradish 5-7 4,500 40,000 H2O2/2,2’-azino-di(3-ethylbenzthiazolinesulfonic acid-6)(ABTS)λ = 415nm
H2O2/3,3’,5,5’-tetramethylbenzidine(TMB) λ = 450nm
H2O2/o-phenylenediamine(oPD) λ = 492nm
Glucoseoxidase/peroxidease
Aspergillusniger
4-7 200 186,000 Coupled enzymereaction Glucose +chromogen for HRP
Ureaseperoxidise
Jack beanniger
Glucose +chromogen for HRP
Urease Jack bean 6.5-7.5 10,000 483,000 Urea/bromcresolyellow λ = 588nm
(Adapted from Porstmann & Kiessig, 1992)
Table 1-8: Enzymes commonly used as labels for EIA
Chapter 1: Introduction
38
1.2.3 Advantages of enzyme-immunoassay methods over
radioimmunoassay (Wisdom, 1976)
They provide specific and sensitive assays of wide applicability.
Equipment required is relatively cheap and is widely available.
Reagents are relatively cheap and have a long shelf-life.
A separation step or complicated extraction procedure may not be
required.
The variety of labels available may allow multiple, simultaneous
assays to be performed.
There is potential for automation.
No problem of radiation hazards.
Generally, immunoassay techniques can be a cost effective detection and
quantification method for trace contaminants or toxins in a wide variety of
foods. Most modern immunoassays for environmental and food
contaminants are based on the use of enzyme tracers to provide
quantification signals (Meulenberg, 1997). This is because enzyme-based
assays have appropriate sensitivity for most purposes and have been
developed in a variety of configurations. The long shelf-lives and ease of
distribution of enzyme-based immunoassays also makes them suitable for
field use. Thus, immunoassay is a very useful analytical technique that can
be used for the development of specific and sensitive assays that would
permit the determination of trace residues of contaminants such as
Chapter 1: Introduction
39
mycotoxins or phytotoxins in small volume of samples which could be
otherwise difficult to analyse by other more expensive analytical methods.
Successful development of an immunoassay technique would however
depend on the availability of antibodies with appropriate affinities and
specificities.
1.2.4 Immunoassay applied to food
Immunoassays are highly quantitative analytical methods that at the highest
level comply with strict regulatory requirements mandated by government
agencies, and are mostly used in the clinical diagnostics industry. In addition
to the sensitivity and specificity of immunoassay methods, they are also
simple; they do not require sophisticated instrumentation and toxic organic
solvents, and are relatively cheap compared to chromatographic,
colorimetric, HPLC or other standard procedures (Mickova et al., 2003). The
success of immunoassay in clinical chemistry has encouraged their use in
food analysis. Immunoassays are now widely utilized in food analysis for
determination of food contaminants and in the agrochemical industry for
detection of chemical residues in plants, water and soil (Meulenberg, 1997;
Ramesh et al., 2007; Sathe et al., 2012). Different types of immunoassay
techniques have been developed for the detection and quantification of
hazardous compounds in food. Quan et al. (2006) developed a sensitive
enhanced chemiluminescence enzyme linked immunosorbent assay (ECL-
ELISA) for the detection of fumonisin B1 (FB1) in food and animal feeds. An
enzyme-linked immunosorbent assay (ELISA) developed by Pastor-Navarro
Chapter 1: Introduction
40
et al. (2007), was able to detect different tetracycline residues in honey. In
another study, Chen et al. (2007) developed a sensitive ELISA method for
monitoring neomycin (an aminoglycoside antibiotic) residue levels in milk
and other biological matrices. Recently, electrochemical immunoassays
have been developed for detection of zearalenone mycotoxin in foods and
are very useful because of their suitability for mass production, high
sensitivity, large number of labels and nanotechnology applications (Hervás
et al., 2009). Extensive research has been carried out on the development
and use of immunoassay for the detection of mycotoxins (such as ochratoxin
A, and aflatoxin B1) (Morgan et al., 1983a; Ward et al., 1990; Yu et al.,
2005), residual insecticides and herbicides in several food commodities
(Krikunova et al., 2002; Bo et al., 2008). Immunoassay has also been used
for the determination of traces of peanut protein contamination in complex
food matrices (Morgan et al., 1986; Mills et al., 1997; Holzhauser & Vieths,
1999).
Mycotoxin toxicity represents a considerable hazard in the nutrition of man
and farm animals. Classical methods (such as HPLC) for mycotoxin
determination are time consuming in terms of sample preparation. High
sensitivity and specificity of immunoassay make it possible to minimize the
size of samples required and the volume of extracting solvents and to omit
the time-consuming purification procedures. This is advantageous for routine
analysis and for screening large sets of samples. For instance, an indirect
Chapter 1: Introduction
41
competitive ELISA was recently used to assess aflatoxin B1 and Aspergillus
spp. infection in 1,200 rice samples in India (Reddy et al., 2009).
1.2.4.1 Determination of pesticide residue
The current analytical methods used for the determination of residual
pesticides are high-performance liquid chromatography (HPLC) and gas
chromatography connected with mass spectrometry (GCMS). Although
these methods are sensitive, a lot of time is required for the purification of
the sample extracts. Highly sensitive and specific immunoassay has now
been developed for the determination a number of pesticides and fungicides
and their metabolites. For instance, the immunoassay method developed for
parathion-methyl (a non-systemic organophosphorus) pesticide was very
sensitive (0.2ng/ml) (Kim et al., 2003). In another study, the immunoassay
method developed for fungicide diniconazole determination showed that the
fungicide hexaconazole and tebuconazole do not give a cross reaction with
the antiserum against diniconazole, which is structurally very similar (Jiang
et al., 2011).
Immunoassays are now utilized for the determination of substances
occurring naturally in plant raw-materials, for example glycoalkaloids (which
gives rise to the bitter taste of potatoes) (Morgan et al., 1983; Stanker et al.,
1996).
Chapter 1: Introduction
42
1.3 Antibodies
Antibodies belong to the family of macromolecules known as
immunoglobulins. Immunoglobulins are glycoproteins which are present at
12-15mg/ml in the blood serum. The five immunoglobulin classes in
mammals are IgG, IgM, IgA, IgD and IgE. IgG is one of the most abundant
immunoglobulin classes in terms of concentration, with a molecular mass of
170kDa. It represents 70 to 75% of serum immunoglobulins and constitutes
the majority of the secondary immune response to most antigens (Turner,
1981). IgG antibodies are secreted by plasma cells produced by the B
lymphocytes of the adaptive immune system. Antibody genes are assembled
from pieces of DNA scattered widely throughout the genetic material
(Deshpande, 1996). As the B-cell that produces antibody matures, it
rearranges these gene components such that the new gene and the
antibody it encodes become unique. As the B-cell containing this gene
arrangement proliferates, all its descendants will make this unique antibody
(Paraf & Peltre, 1991).
The basic structure of IgG antibody resembles the letter Y (Figure 1-7). Each
molecule of IgG antibody has two identical heavy polypeptide chains (H) and
two identical light chains (L), which are stabilized and linked by intrachain
and interchain disulfide bonds. The Fc (fragment crystallisable) portion of an
antibody is the stem of the Y shaped molecule that is a dimer of the two last
heavy chain domains while the Fab (fragment antigen binding) is the
remaining upper part. The two upper domains of IgG antibody (Fab), one
Chapter 1: Introduction
43
from an H and one from an L chain facing each other in a tip of the IgG
antibody Y’s arm form the antibody determinant or paratope, and are
uniquely shaped to fit a specific portion of an antigen called “epitope” (Paraf
& Peltre, 1991). The specificity of antigen-antibody reaction makes
antibodies very useful and highly selective reagents in immunoassays.
Figure 1-7: The general structure of antibody (IgG molecule) showing
the heavy and the light chains and the antibody binding site (modified
from Paraf & Peltre, 1991).
Chapter 1: Introduction
44
1.3.1 Antigen-antibody reaction
Antigen and immunogen are terms often used interchangeably. The word
“antigen” is used for a substance that is recognized by antibody in vitro while
“immunogen” defines the antigen which induces antibody production in vivo
and binds specifically to antibody in vitro. Antigens or immunogens can
stimulate the immune system and are able to induce humoral response
when introduced into an animal. Macromolecules such as proteins
(glycoprotein, lipoprotein or nucleoprotein) and polysaccharides are mostly
good immunogens (Catty, 1988). However, antibodies able to bind to small
molecules can also be produced under specific conditions.
Generally, antibodies do not bind to the whole of an antigen, rather they
recognize one of several characteristic surface features of an antigen called
the “epitopes” or “antigenic determinants”. A particular antigen can have
several different epitopes or may have several identical epitopes. Each
antibody is specific for a particular epitope of the antigen. Thus antibodies
are specific for the epitopes rather than the whole antigen molecule.
Antigens are linked to antibody by hydrogen bonds, electrostatic forces, Van
der Waals forces and hydrophobic bonds (Figure 1-8). Because antigens are
not covalently linked to antibody, there is usually a thermodynamic
reversibility of the antigen-antibody reaction (Coico et al., 2003).
Specificity of an antibody for its antigen is related to the antibody’s affinity. A
close fit of an epitope into a paratope will result in high binding forces with a
Chapter 1: Introduction
45
slow dissociation rate of the complex, whereas a loose contact between
epitopes and paratope (which could be due to a poor structural
complementary) results in a low mutual affinity and a great dissociation rate
of the immune complex (Kemeny, 1991).
The antigen-antibody affinity is expressed by an affinity constant KA resulting
from the application of the mass action law to the following equation at
equilibrium:
Free Ag + free Ab
KA = (Ag-Ab) (bound)(Ag) (Ab) (free)
Ag is antigen, Ab is antibody.
KA is obtained by the formula whose terms are concentrations measured at
equilibrium (Benjamini et al., 2000).
.
Ag-Ab complex
Chapter 1: Introduction
46
---------
---------
Figure 1-8: Schematic representation of antigen-antibody linkage
showing the intermolecular forces involved in antibody-antigen
reactions (adapted from Steward, 1984).
+
Antibody Antigen
Hydrogen
bonding
O
N H
H O
N
Electrostatic
- +
-
Van derwaals
- +
+
+
+ -
-
-
Hydrophobic
Waterexcluded
+
Chapter 1: Introduction
47
1.3.2 Antibody production
The immune systems of animals are capable of producing antibodies in
response to the presence of foreign proteins or other molecules within the
tissues of the animal. The intensity of the response is determined by the
size of the immunogen molecule, its chemical characteristics and how
different it is from the animal’s own proteins. The presence of the foreign
protein initiates a sequence of events, mediated by the cells of the immune
system, that lead to the release of antibody molecules in blood and some
body secretion (Burns, 2005). Although, the natural purpose of antibody
production is to protect against invading pathogens, antibodies can be
produced experimentally by the injection of an animal with an analyte
(antigen) alone or bound to a protein carrier to induce the formation of
specific antibodies in the body of the animal. Generally animals are capable
of producing different types of antibodies which can bind at specific sites
(epitope) of the antigen. There are three types of antibody preparations;
polyclonal antibodies (pAb), monoclonal antibodies (mAb) and recombinant
antibodies.
1.3.2.1 Polyclonal antibodies
Polyclonal antibodies are antibodies synthesized by several cell types of
immunized animal lymphocytes. Conventionally, polyclonal antibodies are
produced by immunizing animals with the antigen of interest. Immunization
of animals results in the activation of B-lymphocytes and subsequent
Chapter 1: Introduction
48
antibody production, each different antibody recognizing one epitope; all
antibodies together recognizing hundreds or thousands of epitopes. This
collection of antibodies produced by many different B-cells is termed
“polyclonal” for the various B clones it is derived from. Thus, polyclonal
antibodies are mixtures of different immunoglobulins binding to multiple sites
on the antigen used for immunization. Polyclonal antibodies have been
raised in numerous species including mice, hen, rabbits, goats and sheep
(Kascsak et al., 1987; Clarke et al., 1993; Bean, 2001; Matsumoto et al.,
2005). The choice of host depends on the intended use of the resulting
antibody. Although, goats and sheep are the species of choice for large-
scale antiserum production, rabbit is the most common species of choice for
polyclonal antibodies intended for routine work (Bean, 2001). In addition,
polyclonal antibody raised in rabbits offers the advantage of ready
availability and general high quality of a wide variety of anti-rabbit antibody
secondary detection reagents (Burns, 2005). Polyclonal antibodies are
reagents of choice for general purpose analytical applications in
immunoassay systems. Polyclonal antibodies have been used extensively in
food immunoassay (Ramesh et al., 2007; Burkin et al., 2010; Suárez-
Pantaleón et al., 2010; Jiang et al., 2011; Kondo et al., 2011).
1.3.2.2 Monoclonal antibodies
The production of specific homogeneous antibodies (monoclonal antibodies)
with predefined binding characteristics that can be produced in large
Chapter 1: Introduction
49
amounts from immortal cell lines has been made possible through
hybridoma technology. Monoclonal technology involves the fusing of an
antibody-producing B cell with a myeloma cell line (lacking the DNA salvage
pathway) to generate a continuous growing hyridoma producing single
antibody specificity. Thus, the genes coding for the specific heavy and light
chains are captured from the B cell and expressed by the hybridoma. A
single B cell from the polyclonal mixture which is isolated and immortalized
is termed “monoclonal”. Each mammalian B cell contains the capacity to
produce an antibody that recognizes a single epitope, generally consisting of
6 to 12 amino acids. Although hybridomas are capable of producing large
amounts of antibodies, the antibodies will all be identical and have identical
epitope binding properties (Köhler & Milstein, 1975; Stewart, 2001).
Monoclonal antibodies are generated using either immune rodent spleen
cells or lymphoid cells from other immunized species (Dean & Shepherd,
2000). For example, monoclonal antibodies are produced when antigen-
producing lymphocytes (e.g. splenocytes of immunized mice) are fused with
myeloma cells and the hybrid cells are selected in a particular culture
medium and screened. The antibodies generated may be highly specific with
identical physical, biochemical and immunological properties in addition to
their immortality (Goding, 1996; Fremy & Usleber, 2003). Monoclonal
antibodies are commonly used in immunoassay techniques for pesticides,
herbicides and mycotoxin contamination in agricultural products (Ward et al.,
1990; Schneider & Hammock, 1992; Abad et al., 1997; Moreno et al., 2001;
Qiant et al., 2009; Ackermann et al., 2011; Fang et al., 2011).
Chapter 1: Introduction
50
1.3.2.3 Recombinant antibodies
Advances in specific antibody production have led to recombinant
technology using phage display technology. Recombinant technology has
opened a new route for the generation of antibodies. Instead of
immortalizing B cells for production of monoclonal antibodies, the antibody
heavy (H) and light (L) chain variable region (V) genes are immortalized by
gene technology (Léger & Saldanha, 2000). Recombinant antibody
technology is based on the isolation and sequencing of the genes that
encode antibodies. By altering the sequence of the antibody genes, the
binding sites can be manipulated to give more desirable characteristics
which include increased or broadened specificity and affinity (Choudary et
al., 1995). The DNA coding for specific antibodies and fragments of
antibodies has been introduced into bacteria, yeast and mammalian cell
lines by recombinant molecular genetics techniques. Antibody genes from
hybridomas or lymphocytes from immunized animals are used to construct
libraries of antibody genes. For example, the IgG mRNA of B cells of
immunized animals can be used as a source of variable region (V) gene
libraries. Murine VH and VL genes are amplified using PCR and used to
construct libraries of millions of recombinant single-chain variable fragment
(scFv). ScFv antibodies consist of the variable regions of the light and heavy
chains of antibodies linked via a short peptide spacer. Repertoires of scFv
are cloned into the gene encoding the minor coat protein (gene III) of
filamentous bacteriophage, thus creating a large library of phage, each
displaying an individual heavy and light chain combination. The fusion